Covid Antiviral Treatments
-
{
- All
- News
'Covid Antiviral Treatments' - 2 News Result(s)
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
US Announces $3.2 Billion Plan To Develop Covid Antiviral Treatments
US announced plans on Thursday to spend $3.2 billion to accelerate the development and discovery of antiviral treatments against Covid-19 and future threats.
'Covid Antiviral Treatments' - 2 News Result(s)
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
US Announces $3.2 Billion Plan To Develop Covid Antiviral Treatments
US announced plans on Thursday to spend $3.2 billion to accelerate the development and discovery of antiviral treatments against Covid-19 and future threats.
